Efficacy and safety of full-dose dabrafenib and trametinib combination therapy in a patient on hemodialysis with metastatic melanoma

被引:1
|
作者
Hayakawa, Kazuma [1 ]
Wakimoto, Hiroko [1 ]
Mae, Kenichihro [1 ]
Irisawa, Ryokichi [1 ]
Harada, Kazutoshi [1 ]
机构
[1] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo, Japan
关键词
D O I
10.1111/ijd.15298
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:516 / 517
页数:2
相关论文
共 50 条
  • [31] Interim Analysis of the Efficacy and Safety of Dabrafenib and Trametinib in Patients with metastatic Melanoma in daily clinical Practice (COMBI-r)
    Berking, C.
    Livingstone, E.
    Weichenthal, M.
    Leiter-Stoeppke, U.
    Wittmann, K.
    Eigentler, T.
    Mohr, P.
    Kiecker, F.
    Loquai, C.
    Debus, D.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 72 - 73
  • [32] Full-dose chemotherapy for esophageal cancer patient under hemodialysis
    Kurisu, A
    Hata, T
    Owada, A
    NEPHRON, 2002, 92 (04): : 960 - 960
  • [33] Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy
    Gargiulo, Luigi
    Tronconi, Maria Chiara
    Grimaudo, Maria S.
    Pavia, Giulia
    Valenti, Mario
    Manara, Sofia
    Costanzo, Antonio
    Borroni, Riccardo G.
    MELANOMA RESEARCH, 2021, 31 (06) : 586 - 588
  • [34] Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma
    Muto, Yusuke
    Fujimura, Taku
    Kambayashi, Yumi
    Ohuchi, Kentaro
    Amagai, Ryo
    Okuma, Takami
    Furudate, Sadanori
    Hashimoto, Akira
    Aiba, Setsuya
    JOURNAL OF DERMATOLOGY, 2021, 48 (03): : E135 - E136
  • [35] An unusual case with multiple epidermotropic melanoma metastases developing under combination therapy with dabrafenib and trametinib
    Gebhardt, C.
    Larribere, L.
    Maurier, N.
    Wetzel, S.
    Orouji, A.
    Utikal, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 56 - 56
  • [36] Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma
    Sasaki, K.
    Uehara, J.
    Iinuma, S.
    Doi, H.
    Honma, M.
    Toki, Y.
    Ishida-Yamamoto, A.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1602 - 1603
  • [37] 24-HOUR EFFICACY AND SAFETY OF FULL-DOSE, TRIPLE-COMBINATION THERAPY WITH OLMESARTAN, AMLODIPINE, AND HYDROCHLOROTHIAZIDE: THE TRINITY STUDY
    Izzo, J.
    Melino, M.
    Fernandez, V.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2010, 28 : E100 - E100
  • [38] Discrepancy in responses to dabrafenib plus trametinib combination therapy in intracranial and extracranial metastases in melanoma patients
    Kobayashi, Tadahiro
    Matsumoto, Sara
    Shimizu, Kyoko
    Miyake, Miho
    Maeda, Shintaro
    Hamaguchi, Yasuhito
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGY, 2021, 48 (02): : E82 - E83
  • [39] A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)
    Atkinson, Victoria G.
    Quaglino, Pietro
    Aglietta, Massimo
    Del Vecchio, Michele
    Depenni, Roberta
    Consoli, Francesca
    Bafaloukos, Dimitrios
    Ferrucci, Pier Francesco
    Tulyte, Skaiste
    Krajsova, Ivana
    Ascierto, Paolo A.
    Gueli, Rossana
    Arance, Ana
    Gogas, Helen
    Banerjee, Hiya
    Saliba, Teddy
    de Jong, Egbert
    Neyns, Bart
    CANCERS, 2021, 13 (10)
  • [40] Phase 2 study of the safety and efficacy of pembrolizumab (pembro) in combination with dabrafenib (D) and trametinib (T) for advanced melanoma (KEYNOTE-022).
    Long, Georgina V.
    Hamid, Omid
    Hodi, F. Stephen
    Lawrence, Donald P.
    Atkinson, Victoria
    Starodub, Alexander
    Carlino, Matteo S.
    Fisher, Rosalie Anne
    Miller, Wilson H.
    Maio, Michele
    Butler, Marcus
    Queirolo, Paola
    Ferrucci, Pier Francesco
    Petrella, Teresa M.
    Schachter, Jacob
    Huang, Yingjie
    Diede, Scott J.
    Ebbinghaus, Scot
    Ribas, Antoni
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)